Related Experiment Video
Updated: May 15, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Severe CMV complication following maintenance therapy with rituximab
Lenaïg Le Clech1, Jean-Christophe Ianotto, Isabelle Quintin-Roue
1Department of Clinical Haematology, Institute of Cancerology and Hematology, University Hospital Brest, Brest, France. lenaig.leclech@hotmail.fr
Cytomegalovirus (CMV) encephalitis is a rare infection that immunodeficient patients, mainly where HIV-positive, may suffer from. Several cases were described when complications with the treatment with monoclonal antibodies, like rituximab, for malignant lymphomas. We will describe here the case of a patient, who has developed CMV gastritis, then CMV encephalitis after the treatment of a CLL with a chemotherapy and maintenance therapy with rituximab.
Cytomegalovirus (CMV) encephalitis is a rare infection that immunodeficient patients, mainly where HIV-positive, may suffer from. Several cases were described when complications with the treatment with monoclonal antibodies, like rituximab, for malignant lymphomas. We will describe here the case of a patient, who has developed CMV gastritis, then CMV encephalitis after the treatment of a CLL with a chemotherapy and maintenance therapy with rituximab.
Related Concept Videos
Cytomegalovirus Disease
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Hypersensitivity Reactions: Cytolytic Reactions
Endocarditis III: Medical Management
